The participants are randomized 2:1 to receive either tividenofusp alfa or idursulfase, respectively. Denali believes that such phenomenal progress in the MPS II program will inform and accelerate ...

and idursulfase. Sitharaman also announced that 37 more medicines have been added in the list of medicines which when offered to patients through the Patient Assistance Programme (PAP) by global ...